Obesity and insulin resistance are the central issues in prevention of and care for comorbidities

9Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

Abstract

For a long time the assumption has been that, although weight reduction was necessary and desirable, comorbidities were far more important and needed treatment even if weight loss was not a treatment goal, preferably with medication. This controversy leads to postponement of treatment, and later on causes very intensive medical treatment, thus, raising the health care costs to unacceptable levels, leading to the medicalization of individuals, and a declining of the responsibility of patients for their health, leaving the question of when to regard their own weight as a problem that should be dealt with up to individuals. The central problem is insulin resistance, which leads to a cascade of health problems. This condition should be diagnosed in primary practice and obesity clinics to ensure a better, tailor-made treatment for patients. Treatment should start at the earliest stage possible, when comorbidities are still reversible and includes a personalized dietary advice and counseling, preferably by a dietitian, to tackle insulin resistance. An exercise program is part of the treatment.

Cite

CITATION STYLE

APA

Govers, E. (2015). Obesity and insulin resistance are the central issues in prevention of and care for comorbidities. Healthcare (Switzerland), 3(2), 408–416. https://doi.org/10.3390/healthcare3020408

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free